Sigma Capital

19-09-2024

Memphis Pharmaceuticals (MPCI.CA) - Release from FRA

Source: EGX

Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
Release from the Financial Regulatory Authority stating that the Authority has no objection in principle to publish an invitation to old shareholders to subscribe in the remaining 1,064,866 shares, with a nominal value of 10 pounds per share and with the same subscription conditions mentioned in the previous announcement.

Release from FRA (1,429 KB)